Mondadori Store

Trova Mondadori Store

Benvenuto
Accedi o registrati

lista preferiti

Per utilizzare la funzione prodotti desiderati devi accedere o registrarti

Vai al carrello
 prodotti nel carrello

Totale  articoli

0,00 € IVA Inclusa

Based on the NPT three-part mini series, Do No Harm: The Opioid Epidemic follows author and director, Harry Wiland as he works to unearth the history and truth behind America's rampant opioid crisis, and investigates how this crisis ballooned into an epidemic fueled by Big Pharma's ploys, the medical community's obliviousness, and policymakers lack of oversight.

The Opioid Epidemic is the worst man-made drug epidemic in the history of our nation. More people die each year from an opioid drug overdose than in automobile accidents. The statistics are staggering. Do No Harm spotlights experts, journalists, and public health crusaders who are combating the special interests of Big Pharma and informing the world on how an aggressive pharmaceutical mass marketing campaign for the new drug OxyContin misled doctors and the public into our current crisis of death and addiction.

Wiland highlights the stories of those hit hardest by prescription opioid addiction and overdose death, and sheds light on how whole communities have been ravaged by the spread of addiction. Despite regional health experts, local government, law enforcement, journalists, and the DEA's efforts to combat the epidemic, people continue to die at an alarming rate from prescription drug overdoses.

The chapters of this book chronicle this opioid epidemic in all its complexity from many perspectives including the plight of the millions of Americans who suffer from opioid addiction. People, young and old on the rocky road to recovery, tell their harrowing stories, current victories, and on-going struggles with the disease.

0 recensioni dei lettori  media voto 0  su  5

Scrivi una recensione per "Do No Harm"

Do No Harm
 

Accedi o Registrati  per aggiungere una recensione

usa questo box per dare una valutazione all'articolo: leggi le linee guida
torna su Torna in cima